Adjei AA - Search Results

1

ALK inhibitors in the treatment of advanced NSCLC.

Gridelli C, Peters S, Sgambato A, Casaluce F, Adjei AA, Ciardiello F. Gridelli C, et al. Among authors: adjei aa. Cancer Treat Rev. 2014 Mar;40(2):300-6. doi: 10.1016/j.ctrv.2013.07.002. Epub 2013 Aug 7. Cancer Treat Rev. 2014. PMID: 23931927 Review.

2

MET: a promising anticancer therapeutic target.

Peters S, Adjei AA. Peters S, et al. Among authors: adjei aa. Nat Rev Clin Oncol. 2012 May 8;9(6):314-26. doi: 10.1038/nrclinonc.2012.71. Nat Rev Clin Oncol. 2012. PMID: 22566105 Review.

3

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E; ESMO Guidelines Working Group. Peters S, et al. Among authors: adjei aa. Ann Oncol. 2012 Oct;23 Suppl 7:vii56-64. doi: 10.1093/annonc/mds226. Ann Oncol. 2012. PMID: 22997455 Free article. No abstract available.

4

Strategies for improving outcomes in NSCLC: a look to the future.

Stahel R, Peters S, Baas P, Brambilla E, Cappuzzo F, De Ruysscher D, Eberhardt WE, Felip E, Fennell D, Marchetti A, Paz-Ares L, Adjei AA. Stahel R, et al. Among authors: adjei aa. Lung Cancer. 2013 Dec;82(3):375-82. doi: 10.1016/j.lungcan.2013.08.025. Epub 2013 Sep 8. Lung Cancer. 2013. PMID: 24094287 Free article. Review.

5

Cerebral nocardiosis mimicking multiple brain metastases in a patient with locally advanced non-small-cell lung cancer.

Voide C, Zimmermann S, Adjei AA, Betticher DC, Meuli R, Prod'hom G, Giulieri S, Peters S. Voide C, et al. Among authors: adjei aa. J Thorac Oncol. 2014 Mar;9(3):e24-6. doi: 10.1097/JTO.0000000000000018. J Thorac Oncol. 2014. PMID: 24518096 Free article. No abstract available.

6

Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.

Brechbiel J, Miller-Moslin K, Adjei AA. Brechbiel J, et al. Among authors: adjei aa. Cancer Treat Rev. 2014 Jul;40(6):750-9. doi: 10.1016/j.ctrv.2014.02.003. Epub 2014 Feb 24. Cancer Treat Rev. 2014. PMID: 24613036 Review.

7

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease.

Besse B, Adjei A, Baas P, Meldgaard P, Nicolson M, Paz-Ares L, Reck M, Smit EF, Syrigos K, Stahel R, Felip E, Peters S; Panel Members; ESMO. Besse B, et al. Ann Oncol. 2014 Aug;25(8):1475-84. doi: 10.1093/annonc/mdu123. Epub 2014 Mar 25. Ann Oncol. 2014. PMID: 24669016 Free article.

8

Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug-drug interactions.

Peters S, Zimmermann S, Adjei AA. Peters S, et al. Among authors: adjei aa. Cancer Treat Rev. 2014 Sep;40(8):917-26. doi: 10.1016/j.ctrv.2014.06.010. Epub 2014 Jul 1. Cancer Treat Rev. 2014. PMID: 25027951 Free article.

9

Lung cancer. How much platinum-based chemotherapy is enough in NSCLC?

Peters S, Adjei AA. Peters S, et al. Among authors: adjei aa. Nat Rev Clin Oncol. 2015 Jan;12(1):8-10. doi: 10.1038/nrclinonc.2014.212. Epub 2014 Dec 2. Nat Rev Clin Oncol. 2015. PMID: 25445558

10

BRAF Alterations as Therapeutic Targets in Non-Small-Cell Lung Cancer.

Nguyen-Ngoc T, Bouchaab H, Adjei AA, Peters S. Nguyen-Ngoc T, et al. Among authors: adjei aa. J Thorac Oncol. 2015 Oct;10(10):1396-403. doi: 10.1097/JTO.0000000000000644. J Thorac Oncol. 2015. PMID: 26301799 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

457 results

Search Page